Ernexa Therapeutics (ERNAW) EBITDA Margin Growth (1y) (2011 - 2024)
Ernexa Therapeutics (ERNAW) EBITDA Margin Growth (1y) (2011 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ernexa Therapeutics |
- |
- |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-242,943.00 |
| Sep 30, 2024 |
1.03 Mn |
| Dec 31, 2020 |
5,108.00 |
| Sep 30, 2020 |
-9,215.00 |
| Mar 31, 2020 |
-4,943.00 |
| Dec 31, 2019 |
-2,392.00 |
| Sep 30, 2019 |
-1,240.00 |
| Jun 30, 2019 |
185.00 |
| Mar 31, 2019 |
214.00 |
| Dec 31, 2018 |
696.00 |
| Sep 30, 2018 |
635.00 |
| Jun 30, 2018 |
-74.00 |
| Mar 31, 2018 |
-650.00 |
| Dec 31, 2017 |
-1,952.00 |
| Sep 30, 2017 |
1,166.00 |
| Jun 30, 2017 |
1,347.00 |
| Mar 31, 2017 |
1,978.00 |
| Dec 31, 2016 |
2,791.00 |
| Sep 30, 2016 |
2,120.00 |
| Jun 30, 2016 |
2,603.00 |
